LUPIN LIMITED
🇮🇳India
- Country
- 🇮🇳India
- Ownership
- -
- Established
- 1968-01-01
- Employees
- -
- Market Cap
- $11.9B
- Website
- http://www.lupin.com/
Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions
Phase 1
Completed
- Conditions
- Pharmacokinetic Study
- Interventions
- First Posted Date
- 2012-10-30
- Last Posted Date
- 2012-10-30
- Lead Sponsor
- Lupin Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT01717235
- Locations
- 🇮🇳
Sipra Labs Limited, Hyderabad,, Andhra Pradesh,, India
Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fed Conditions
Phase 1
Completed
- Conditions
- Pharmacokinetic Study
- Interventions
- First Posted Date
- 2012-10-26
- Last Posted Date
- 2012-10-26
- Lead Sponsor
- Lupin Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT01714856
- Locations
- 🇮🇳
Sipra Labs Limited, Hyderabad, Andhra Pradesh, India
Two Way Cross Over BE Fasting Pilot Study of Ropinirole Hydrochloride CR 2mg Tablets
Phase 1
Completed
- Conditions
- Pharmacokinetic Study
- Interventions
- Drug: Test Product (Ropinirole)Drug: Reference Product (REQUIP )
- First Posted Date
- 2012-10-23
- Last Posted Date
- 2012-10-23
- Lead Sponsor
- Lupin Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT01712568
- Locations
- 🇮🇳
Sipra Labs Limited, Hyderabad, Andhra Pradesh, India
© Copyright 2025. All Rights Reserved by MedPath